RCT Study of Levosimendan Improving Prognosis of Cardiac Arrest
Clinical trial NCT05956431 · UNKNOWN
Trial details
- NCT number
- NCT05956431
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.